Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy.
Theranostics
; 13(14): 5075-5098, 2023.
Article
in En
| MEDLINE
| ID: mdl-37771778
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Theranostics
Year:
2023
Type:
Article